US Patent Office Rejects Ethicon’s Petition for Inter Partes Review of EndoEvolution’s Patent Medical Device Investing
Inovio Pharmaceuticals Completes Acquisition of Needle-Free Injection Technology Pharmaceutical Investing
Tonix Pharmaceuticals Completes Enrollment in Phase 3 Clinical Trial of TNX-102 SL in Fibromyalgia Life Science Investing
Ohr Pharmaceutical Announces Appointment of David Brown, MD as Chair of Phase 3 Clinical Program Steering Committee Life Science Investing
Hitachi Medical Systems America Announces Unique All-Inclusive Program for Scenaria SE 64/128 CT Medical Device Investing
Ignyta Announces Full Exercise of Underwriters’ Option to Purchase Additional Shares Biotech Investing
Fresenius Renal Therapies Announces the Introduction of Next Generation Sentinel Technology to Support Fluid Management Challenges in the End Stage Renal Disease Community Medical Device Investing
Homology Medicines Inc. Launches as a Newly-Formed Genetic Medicines Company Founded Upon a Unique City of Hope Gene Editing and Gene Transfer Platform Technology Genetics Investing
Oligomerix Awarded a Grant for its Alzheimer’s Drug Discovery Program Targeting Tau Oligomers from the National Institutes of Health Biotech Investing
Progenics Licenses PSMA Antibody Technology to Bayer for Development of Alpha-Radiolabeled Therapeutic Antibodies Life Science Investing
Gordagen Reports Top-line Results of US Human Research (Clinical) Study for Muscle Recovery Supplement Life Science Investing
BriaCell and BriaPro to Present Preclinical Anti-Cancer Activity and Immunotherapy Findings at SITC 2026Â
